维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

4篇 您的检索式：作者名="Matthew Old"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Protein as a regulator of pancreatic enzyme secretion in the rat显示文摘	GREEN G M OLDS B A MATTHEWS G	1973	Experimental Biology and Medicine1973，142，4：	1
	2	Emerging role of nanog in tumorigenesis and cancer stem cells显示文摘	Luis E. IV Santaliz‐Ruiz Xiujie Xie Matthew Old Theodoros N. Teknos Quintin Pan	2014	Cancer2014，，12：	1
	3	Identification of Breast Cancer-Restricted Antigens by Antibody Screening of SKBR3 cDNA Library Using a Preselected Patient’s Serum显示文摘	Stefania Forti Matthew J. Scanlan AnnaMaria Invernizzi Fabio Castiglioni Sandro Pupa Roberto Agresti Rosanna Fontanelli Daniele Morelli Lloyd J. Old Serenella M. Pupa Sylvie Ménard	2002	Breast Cancer Research and Treatment2002，，3：	1
	4	Review of cost and surgical time implications using virtual patient specific planning and patient specific implants in midface reconstruction显示文摘Aim:Summarize the available data on midfacial virtual patient specific planning and patient specific implants,highlighting the financial costs and savings,and additionally emphasize the potential cost implications of transitioning to“in-house”virtual 3D modeling and printing.Methods:Review of current literature.Results:Current literature suggests cost benefits of virtual patient specific planning and patient specific implants in the form of improved ischemia time,better boney apposition between flaps,and reduced patient complications.This reduction of complications includes a reduction in blood loss and time spent in the intensive care unit from flap failure.Improved boney apposition results in a higher likelihood of boney union and a further reduction in failure and complications.Subjective benefits of virtual patient specific planning and patient specific implants are shown in the form of improved reconstructive surgeon mental energy.In-house production of 3D models and presurgical planning provides additional cost benefits for providers as they can produce viable models at a fraction of the price of that which is produced by industrial companies.Providers can also construct and use models in an expedient manner compared to industrial models,allowing for the opportunity to be utilized in more acute settings.The foundation of developing an in-house workflow is adequate funding,resources,and clinical volume.Facilities also must focus on appropriate quality and safety measures,as well as appropriate workflow development for adequate production of models.Conclusion:Virtual patient specific planning and patient specific implants show benefits in midfacial reconstructive outcomes,resulting in realized financial and temporal gains for both patient and provider.These gains may be enhanced by moving to in-house planning and printing.	Michael Lawless Brian Swendseid Natalia von Windheim Kyle VanKoevering Nolan Seim Matthew Old	2022	Plastic and Aesthetic Research2022，9，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费